InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Chee Conley. Officer active across 1 company, notably Syros Pharmaceuticals, Inc.. Cumulatively, 6 reports have been recorded. Split: 1 buy · 1 sell. Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Chee Conley is linked to Syros Pharmaceuticals, Inc. as President & CEO. There are 6 filings in total, and among the sampled recent filings the period runs from 2023-04-04 to 2024-11-20, with one buy and one sell indicated, while the most frequent transaction nature is Option exercise.